Acropolis Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,265	Closed	-$149K	–	308
2024 Q3	$149K	Sell	2,265 -3	-0.1%	-$218	0.01%	259
2024 Q2	$209K	Buy	2,268 +3	+0.1%	+$266	0.01%	216
2024 Q1	$216K	Sell	2,265 -600	-21%	-$50.4K	0.01%	214
2023 Q4	$218K	Buy	2,865 +1	+0%	+$70	0.02%	210
2023 Q3	$198K	Sell	2,864 -2	-0.1%	-$161	0.02%	214
2023 Q2	$270K	Buy	2,866 +1	+0%	+$87	0.02%	181
2023 Q1	$237K	Hold	2,865	–	–	0.02%	186
2022 Q4	$214K	Buy	2,865 +5	+0.2%	+$385	0.02%	186
2022 Q3	$236K	Hold	2,860	–	–	0.02%	171
2022 Q2	$272K	Hold	2,860	–	–	0.03%	166
2022 Q1	$337K	Hold	2,860	–	–	0.03%	147
2021 Q4	$371K	Hold	2,860	–	–	0.03%	145
2021 Q3	$323K	Hold	2,860	–	–	0.04%	147
2021 Q2	$296K	Hold	2,860	–	–	0.03%	150
2021 Q1	$239K	Buy	2,860 +600	+27%	+$50.7K	0.02%	159
2020 Q4	$206K	Hold	2,260	–	–	0.02%	167
2020 Q3	$180K	Buy	+2,260	New	+$176K	0.02%	164